Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer

Triple positive breast cancer (TPBC) is one of the most aggressive breast cancer. Due to the unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets, chemotherapy is the choice of treatment for TNBC. Doxorubicin (DOX), one of the representative agents of anthracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Weiwei, Luo, Yuning, Gan, Dali, Zhang, Yaofeng, Deng, Huan, Liu, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693343/
https://www.ncbi.nlm.nih.gov/pubmed/38047286
http://dx.doi.org/10.3389/fbioe.2023.1271420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693343/
https://www.ncbi.nlm.nih.gov/pubmed/38047286
http://dx.doi.org/10.3389/fbioe.2023.1271420

Ejemplares similares